FEZF1-AS1 has been reported to regulate tumor progression in various cancers, including hepatocellular carcinoma [14], gastric cancer [15] and other human malignancies, and is associated with poor prognosis [16]. This evidence concerns the gene FEZF1 and neoplasm.